Asia Pacific Anti Snoring Devices Market Size is anticipated to grow at 11.54% CAGR from 2018 to 2023 and it is estimated that the Asia Pacific market was valued at USD 0.13 billion in 2018 and is expected to reach USD 0.23 billion by 2023. Snoring is common sleep disorders is a result of the repetitive narrowing and collapsing of the upper airway. Untreated snoring is often associated with multiple adverse health outcomes including systemic hypertension, coronary artery disease, stroke and atrial fibrillation. Snoring is also considered as a significant social problem and leads to a poorer quality of life for bed partners through disrupted sleep. Treatment for snoring involves either anti-snoring devices or by doing an appropriate surgery. Common surgery includes uvulopalatopharyngoplasty surgery, tonsillectomy and adenoidectomy surgery, maxillo-mandibular and genioglossus advancement surgeries, radiofrequency ablation surgery.
Some major factors stimulating the market growth are an increase in the awareness among individuals about the ill effects of snoring, soaring geriatric and obese population, the presence of an untapped population pool characterized by a snoring condition, and the increasing consumption of alcohol and cigarettes. The subsequent health risks associated with this condition are sleep apnea, interrupted breathing, and strain on the heart. These conditions have stimulated the population to opt for treatment solutions including non-surgical appliances and surgical options, which in turn has led to the growth of the overall industry. Be that as it may, factors, such as the high-cost of these surgeries, limited efficacy of the current treatments available for this condition, and unpropitious reimbursement issues are likely to deter the growth of the anti-snoring devices and snoring surgery market. Moreover, disadvantages to the use of the non-surgical equipment, such as dry mouth, jaw discomfort, and hyper salivation serve as strong deterrents that discourage their use among the patients.
Asia Pacific Anti Snoring Devices Market Segmentation by Device Type and Surgical Procedure. On the basis of Device Type, it is segmented MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, and EPAP. The oral appliances segment is expected to account for the largest share of the market, followed by the nasal devices segment. The oral appliances segment is projected to register the highest CAGR during the forecast period, due to the growth in awareness among dentists and patients regarding the use of oral appliances, a recommendation as the first line of anti-snoring treatment from health organizations in several regions, and launch of new and advanced products. On the basis of Surgical Procedure, it is segmented UP3, LAUP, RFA, Sclerotherapy, Pillar, and Others.
Asia Pacific Anti Snoring Devices Market geographical segmentation by India, China, Japan, Australia and South Korea. Asia Pacific is anticipated to register the highest growth rate due to an availability of large pool of untreated individuals with a snoring condition and the high level of awareness associated with this condition.
The major Asia Pacific Anti Snoring Devices Market leaders are Sleeping Well LLC, Apnea Sciences Corporation, Tomed Dr. Toussaint Gmbh, AccuMED Corp., Fisher & Paykel Healthcare, Apnea Sciences Corporation, ImThera Medical Inc., ResMed Inc., SomnoMed, Sleep Well Enjoy Life, Ltd., MEDiTAS Ltd., and Nasal Devices.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device Type
5.1.1 Introduction
5.1.2 Oral Appliances/Mouthpieces
5.1.2.1 Mandibular Advancement Devices (MADS)
5.1.2.1.1 Non-Custom MADS
5.1.2.1.2 Custom-Made MADS
5.1.2.2 Tongue-Retaining Devices (TRDS)
"5.1.3 Nasal Devices
"
5.1.3.1 External Nasal Dilators (Nasal Strips)
5.1.3.2 Other Nasal Devices
5.1.4 Position Control Devices
5.1.5 Chin Straps
5.1.6 Tongue-Stabilizing Devices (TSDs)
"5.1.7 Epap Therapy Devices
"
5.1.8 Y-o-Y Growth Analysis, By Device Type
5.1.9 Market Attractiveness Analysis, By Device Type
5.1.10 Market Share Analysis, By Device Type
5.2 Surgical Procedures
5.2.1 Introduction
5.2.2 Uvulopalatopharyngoplasty (UPPP)
5.2.3 Laser-Assisted Uvulopalatoplasty (Laup)
5.2.4 Radiofrequency Ablation (Somnoplasty)
5.2.5 Pillar Procedure
5.2.6 Injection Snoreplasty/Sclerotherapy
5.2.7 Palatal Stiffening Procedures
5.2.8 Other Anti-Snoring Surgical Procedures
5.2.9 Y-o-Y Growth Analysis, By TSurgical Proceduresype
5.2.10 Market Attractiveness Analysis, By Surgical Procedures
5.2.11 Market Share Analysis, By Surgical Procedures
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Device Type
6.1.3.3 By Surgical Procedures
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Device Type
6.1.4.3 By Surgical Procedures
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device Type
6.1.5.3 By Surgical Procedures
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Sleeping Well LLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Apnea Sciences Corporation
8.3 Tomed Dr. Toussaint Gmbh
8.4 AccuMED Corp.
8.5 Fisher & Paykel Healthcare
8.6 Apnea Sciences Corporation
8.7 ImThera Medical Inc.
8.8 ResMed Inc.
8.9 SomnoMed
8.10 Nasal Devices.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
